




Searching News Database: genomic test
HSMN NewsFeed - 21 Nov 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
HSMN NewsFeed - 3 Mar 2020
DxTerity Receives CE Mark for DxCollect(R) Fingerstick Blood RNA Stabilization Device
DxTerity Receives CE Mark for DxCollect(R) Fingerstick Blood RNA Stabilization Device
HSMN NewsFeed - 13 Feb 2020
Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer
Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer
HSMN NewsFeed - 30 Dec 2019
Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
HSMN NewsFeed - 19 Jun 2018
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
HSMN NewsFeed - 22 Feb 2018
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
HSMN NewsFeed - 20 Feb 2017
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
HSMN NewsFeed - 17 Jan 2017
Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development
Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development
HSMN NewsFeed - 19 May 2016
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
HSMN NewsFeed - 4 Feb 2016
GenomeDx Publishes First Study Supporting Use of Decipher Test in Prostate Biopsy
GenomeDx Publishes First Study Supporting Use of Decipher Test in Prostate Biopsy
HSMN NewsFeed - 28 Oct 2015
Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates
Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates
HSMN NewsFeed - 15 Oct 2015
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
HSMN NewsFeed - 7 Jul 2014
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
HSMN NewsFeed - 17 Feb 2014
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
HSMN NewsFeed - 19 Dec 2013
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
HSMN NewsFeed - 9 Dec 2013
LabCorp to Offer the IntelliGENTM Multi-Gene Oncology Panel on the Next Generation Sequencing Platform
LabCorp to Offer the IntelliGENTM Multi-Gene Oncology Panel on the Next Generation Sequencing Platform
HSMN NewsFeed - 12 Apr 2013
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
HSMN NewsFeed - 25 Sep 2012
Life Technologies Launches Pervenio(TM) Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
Life Technologies Launches Pervenio(TM) Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
HSMN NewsFeed - 3 Jun 2011
Breast Cancer Genomic Test Shown to Predict Patient Survival Following Adjuvant Chemotherapy
Breast Cancer Genomic Test Shown to Predict Patient Survival Following Adjuvant Chemotherapy
HSMN NewsFeed - 20 Jan 2010
Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
HSMN NewsFeed - 17 Nov 2009
New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
HSMN NewsFeed - 28 Oct 2009
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
HSMN NewsFeed - 1 Jul 2009
LabCorp Commences Cash Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc.
LabCorp Commences Cash Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc.
HSMN NewsFeed - 2 Jun 2009
Clinical Data, Inc. Announces Positive Results from Second Phase III Trial of Vilazodone for Depression
Clinical Data, Inc. Announces Positive Results from Second Phase III Trial of Vilazodone for Depression
HSMN NewsFeed - 7 May 2009
Ipsogen Launches a New Test to Guide Hormonotherapy Prescription in Breast Cancer
Ipsogen Launches a New Test to Guide Hormonotherapy Prescription in Breast Cancer
HSMN NewsFeed - 18 Feb 2009
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
HSMN NewsFeed - 17 Feb 2009
Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
HSMN NewsFeed - 4 Feb 2009
Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
HSMN NewsFeed - 12 Dec 2008
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
HSMN NewsFeed - 16 May 2008
LabCorp First Company to Commercially Launch Gene Methylation Test for Prostate Cancer
LabCorp First Company to Commercially Launch Gene Methylation Test for Prostate Cancer
HSMN NewsFeed - 5 May 2008
ParagonDx Receives FDA 510(k) Marketing Clearance for Warfarin Sensitivity Genotyping Kit
ParagonDx Receives FDA 510(k) Marketing Clearance for Warfarin Sensitivity Genotyping Kit
HSMN NewsFeed - 17 Jan 2008
LabCorp Licenses Technology for Early Detection of Lung Cancer from Duke University
LabCorp Licenses Technology for Early Detection of Lung Cancer from Duke University
HSMN NewsFeed - 25 Oct 2007
LabCorp(R) Launches Integrated and Sequential Prenatal Screening Technology for Down Syndrome
LabCorp(R) Launches Integrated and Sequential Prenatal Screening Technology for Down Syndrome
HSMN NewsFeed - 29 Aug 2007
ParagonDx Prepares Molecular Diagnostics Expansion After Acquisition of Gentris Diagnostics, Inc.
ParagonDx Prepares Molecular Diagnostics Expansion After Acquisition of Gentris Diagnostics, Inc.
HSMN NewsFeed - 21 Jun 2007
Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
HSMN NewsFeed - 29 May 2007
LabCorp(R) Licenses Gene Methylation Technology for Prostate Cancer from Veridex, LLC
LabCorp(R) Licenses Gene Methylation Technology for Prostate Cancer from Veridex, LLC
HSMN NewsFeed - 25 Apr 2007
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
HSMN NewsFeed - 13 Feb 2007
Carl Hull to Join Gen-Probe as Executive Vice President and Chief Operating Officer
Carl Hull to Join Gen-Probe as Executive Vice President and Chief Operating Officer
HSMN NewsFeed - 5 Feb 2007
Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics
Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics
HSMN NewsFeed - 21 Jul 2006
LabCorp(R) Announces Succession Plan; David P. King to Succeed Thomas P. Mac Mahon as CEO on January 1, 2007
LabCorp(R) Announces Succession Plan; David P. King to Succeed Thomas P. Mac Mahon as CEO on January 1, 2007
Additional items found! 26

Members Archive contains
26 additional stories matching:
genomic test
(Password required)
genomic test
(Password required)